Patents by Inventor Leon Ellenbogen

Leon Ellenbogen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutritional supplement to treat macular degeneration
    Patent number: 8603522
    Abstract: A daily nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The ingredients of the daily nutritional or dietary supplement composition include vitamin C, vitamin E, lutein, zinc and copper. The ingredients are preferably provided in a tablet form suitable for oral ingestion.
    Type: Grant
    Filed: January 13, 2005
    Date of Patent: December 10, 2013
    Assignee: Bausch & Lomb Incorporated
    Inventors: Stephen Paul Bartels, Cara Larraine Baustian, George Edwin Bunce, Leon Ellenbogen, Frederick L. Ferris, III, Jin Kinoshita, James Cecil Smith, Jr., David A. Souerwine
  • Nutritional supplement to treat macular degeneration
    Publication number: 20050163864
    Abstract: A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.
    Type: Application
    Filed: January 13, 2005
    Publication date: July 28, 2005
    Applicant: Bausch & Lomb Incorporated
    Inventors: Stephen Bartels, Cara Baustian, George Bunce, Leon Ellenbogen, Frederick Ferris, Jin Kinoshita, James Smith, David Souerwine
  • Nutritional supplement to treat macular degeneration
    Publication number: 20040052863
    Abstract: A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.
    Type: Application
    Filed: August 15, 2003
    Publication date: March 18, 2004
    Inventors: Stephen Paul Bartels, Cara Larraine Baustian, George Edwin Bunce, Leon Ellenbogen, Frederick L. Ferris, Jin Kinoshita, James Cecil Smith, David A. Souerwine
  • Nutritional supplement to treat macular degeneration
    Patent number: 6660297
    Abstract: A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: December 9, 2003
    Assignee: Bausch & Lomb Incorporated
    Inventors: Stephen Paul Bartels, Cara Larraine Baustian, George Edwin Bunce, Leon Ellenbogen, Frederick L. Ferris, III, Jin Kinoshita, James Cecil Smith, Jr., David A. Souerwine
  • Nutritional supplement to treat macular degeneration
    Publication number: 20020182266
    Abstract: A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.
    Type: Application
    Filed: March 23, 2001
    Publication date: December 5, 2002
    Inventors: Stephen Paul Bartels, Cara Larraine Baustian, George Edwin Bunce, Leon Ellenbogen, Frederick L. Ferris, Jin Kinoshita, James Cecil Smith, David A. Souerwine
  • Calcium dietary supplement
    Patent number: 5879698
    Abstract: A dietary supplement composition is disclosed which comprises a calcium salt, vitamin D and at least one mineral, preferably a boron compound. Other minerals may be present, in addition to, or instead of the boron compound, such as copper compounds, Magnesium compounds, manganese compounds and zinc compounds.
    Type: Grant
    Filed: April 3, 1997
    Date of Patent: March 9, 1999
    Assignee: American Cyanamid Company
    Inventors: Leon Ellenbogen, Lisa C. Buono
  • Prenatal iron supplements
    Patent number: 4431634
    Abstract: Multimineral dietary supplement compositions of enhanced iron bioavailability are provided by the use of controlled quantities of oxides and carbonates of calcium and magnesium.
    Type: Grant
    Filed: December 21, 1981
    Date of Patent: February 14, 1984
    Assignee: American Cyanamid Company
    Inventor: Leon Ellenbogen
  • 4-Biphenylacetic acid as an inhibitor of platelet aggregation
    Patent number: 3966978
    Abstract: The use of 4-biphenylacetic acid in the amelioration of blood platelet aggregation.
    Type: Grant
    Filed: April 25, 1975
    Date of Patent: June 29, 1976
    Assignee: American Cyanamid Company
    Inventors: Leon Ellenbogen, Constance Anne Kohler
  • 3-(4-Biphenylcarbonyl)propionic acid as an inhibitor of platelet aggregation
    Patent number: 3966960
    Abstract: The use of 3-(4-biphenylcarbonyl)propionic acid in the treatment of blood platelet aggregation.
    Type: Grant
    Filed: April 25, 1975
    Date of Patent: June 29, 1976
    Assignee: American Cyanamid Company
    Inventors: Leon Ellenbogen, Constance Anne Kohler